Abstract:The vascular endothelial growth factor receptors (VEGFRs) bind to cognate ligands to facilitate signaling pathways critical for angiogenesis, the growth of new capillaries from existing vasculature. Intracellular trafficking regulates the availability of receptors on the cell surface to bind ligands, which regulate activation, and the movement of activated receptors between the surface and intracellular pools, where they can initiate different signaling pathways. Using experimental data and computational modeling, we recently demonstrated and quantified the differential trafficking of three VEGF receptors, VEGFR1, VEGFR2, and coreceptor Neuropilin-1 (NRP1). Here, we expand that approach to quantify how the binding of different VEGF ligands alters the trafficking of these VEGF receptors and demonstrate the consequences of receptor localization and ligand binding on the localization and dynamics of signal initiation complexes. We include simulations of four different splice isoforms of VEGF-A and PLGF, each of which binds to different combinations of the VEGF receptors, and we use new experimental data for two of these ligands to parameterize and validate our model. We show that VEGFR2 trafficking is altered in response to ligand binding, but that trafficking of VEGFR1 is not; we also show that the altered trafficking can be explained by a single mechanistic process, increased internalization of the VEGFR2 receptor when bound to ligand; other processes are unaffected. We further show that even though the canonical view of receptor tyrosine kinases is of activation on the cell surface, most of the ligand-receptor complexes for both VEGFR1 and VEGFR2 are intracellular. We also explore the competition between the receptors for ligand binding, the so-called decoy effect, and show that while in vitro on the cell surface minimal such effect would be observed, inside the cell the effect can be substantial and may influence signaling. We term this location dependence the reservoir effect as the size of the local ligand reservoir (large outside the cell, small inside the cell) plays an integral role in the receptor-receptor competition. These results expand our understanding of receptor-ligand trafficking dynamics and are critical for the design of therapeutic agents to regulate ligand availability to VEGFR1 and hence VEGF receptor signaling in angiogenesis.

Molecular Pharmacology of VEGF-A Isoforms: Binding and Signalling at VEGFR2

A Structural Overview of Vascular Endothelial Growth Factors Pharmacological Ligands: From Macromolecules to Designed Peptidomimetics

Molecular Bases of VEGFR-2-Mediated Physiological Function and Pathological Role

VEGFA, B, C: Implications of the C-Terminal Sequence Variations for the Interaction with Neuropilins

Biology and therapeutic targeting of vascular endothelial growth factor A

VEGF receptor signalling ? in control of vascular function

The biology of VEGF and its receptors

Mechanisms and regulation of endothelial VEGF receptor signalling

The vascular endothelial growth factor (VEGF)/VEGF receptor system and its role under physiological and pathological conditions

The Role of Heterodimerization Between VEGFR-1 and VEGFR-2 in the Regulation of Endothelial Cell Homeostasis

Role of PlGF in the intra- and intermolecular cross talk between the VEGF receptors Flt1 and Flk1

VEGFR1 signaling in retinal angiogenesis and microinflammation

Molecular and functional diversity of vascular endothelial growth factors

VEGF-A mRNA processing, stability and translation: a paradigm for intricate regulation of gene expression at the post-transcriptional level

Vascular endothelial growth factor family of ligands and receptors: review

Impact of ligand binding on VEGFR1, VEGFR2, and NRP1 localization in human endothelial cells

Novel VEGF Family Members: VEGF-B, VEGF-C and VEGF-D.

VEGFA and tumour angiogenesis

VEGF-A/VEGFR2 signaling network in endothelial cells relevant to angiogenesis

Vascular endothelial growth factor (VEGF), VEGF receptors and their inhibitors for antiangiogenic tumor therapy

Positive and Negative Regulation of Angiogenesis by Soluble Vascular Endothelial Growth Factor Receptor-1